Could One Dose of HPV Vaccine Be Enough?

0
2


FRIDAY, Dec. 27, 2019 — In a finding that might make the HPV vaccine more palatable to many, new research suggests a single dose may provide just as much protection from cervical cancer as the recommended two to three doses do. ” The vaccine is…

Related Links:

This study aims to understand and compare the level of knowledge, the attitude and the awareness of cervical cancer, HPV infection and vaccination among medical students from across the globe. It was conducted by sharing a questionnaire on medical students ’ Facebook groups. We successfully analysed 736 responses, of which 74.3% were females and 25.7% males. Their mean age was 23.14. As regards to the respondents’ knowledge of the risk factors for cervical cancer, 28.8% of the participants identified HPV, 23.5% chose “Having many sexual partners ”, 15.4% identified “Starting the sexual life at…

This study indicates a high HPV infection rate in women in the city of Zhengzhou and a large percentage of women are infected with single or multiple high-r isk HPV genotypes that cannot be prevented using the current nonavalent HPV vaccine. Vaccines incorporating more HPV genotypes and extended age coverage for the current nonavalent vaccine might be necessary to better prevent HPV-related cervical cancer.

Publication date: Available online 3 January 2020Source: Preventive MedicineAuthor(s): Colin Malone, Ruanne V. Barnabas, Diana S.M. Buist, Jasmin A. Tiro, Rachel L. WinerAbstractHPV self-sampling (HPV-SS) can increase cervical cancer screening participation by addressing barriers in high- and low- and middle-income settings. Successful implementation of HPV-SS programs will depend on understanding potential costs and health effects. Our objectives were to summarize the methods and results of published HPV-SS cost and cost-effectiveness studies, present implications of these results for HPV-SS program implementation, and id…

Source: Preventive MedicineCategory: International Medicine & Public Health Source Type: research

AbstractIn 2017, HPV vaccines were first marketed in China. We carried out an investigation among parents of high school students to assess parents ’ knowledge of cervical cancer and human papillomavirus (HPV)/HPV vaccines, along with their acceptance of HPV vaccination and the factors that influence it, all of which are essential for targeted education regarding HPV vaccination. A cross-sectional study was conducted among parents of high sch ool students in East China using a pretested questionnaire. Data regarding knowledge of cervical cancer, HPV, HPV vaccines, and acceptance of the vaccines were collected and ana…

Vaccination against HPV seems to be a good approach for prevention of cervical cancer and genital warts. But in Iran we are confronted with lack of evidence for its cost-effectiveness whereas its consumption is dramatically increasing. This was a cross- sectional study. We used a questionnaire included 5 sections as follows; Patients demographic information, Patients medical history, Pregnancy and lactation considerations, Gardasil prescription characteristics and HPV infection characteristics. Prescriber with adherence to guideline were defined as those prescribing Gardasil for correct age range and indication with accura…

Purpose of review
Although cervical cancer continues to decrease in incidence throughout the developed world because of rigorous screening and vaccination campaigns, the disease remains a major cause of cancer-related morbidity and mortality in resource-limited regions including sub-Saharan Africa. This review summarizes current efforts to implement cost-effective and widespread cervical cancer education, screening, and community-based interventions in Africa and the challenges faced by local healthcare workers.
Recent findings
Effective screening with cytology (with or without high-risk human papillomavirus [HPV] DNA…

Treatment could clear up persistent infections and reduce risk of cervical cancerThe broadest vaccine yet that could clear up persistent HPV infections and reduce the risk of women developing cervical cancer is to be tested in a clinical trial.Human papillomavirus infections are common and are generally cleared by the body. However, about 10% of infections are not cleared, with persistent infections of certain types of HPV known to increase the risk of a number of cancers, including cervical cancer.Continue reading…

Source: Guardian Unlimited ScienceCategory: Science Authors: Tags: HPV vaccine Medical research Cervical cancer UK news Science Health Women Life and style Society Vaccines and immunisation World news Source Type: news

First introduced in 2006, the multi-dose human papillomavirus (HPV) vaccine can prevent most cervical and anal cancers among children and young adults exposed to the virus. It can also prevent the majority of both HPV-driven oral and penile cancers.

Source: WebMD HealthCategory: Consumer Health News Source Type: news

FRIDAY, Dec. 27, 2019 — In a finding that might make the HPV vaccine more palatable to many, new research suggests a single dose may provide just as much protection from cervical cancer as the recommended two to three doses do. ” The vaccine is…

Conclusion: It was determined that the knowledge level and attitudes of the participant women about HPV, cervical cancer, and Pap smear test were insufficient.



Source link